|
SNX16 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.765600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.700200E-01 |
| Normal-vs-Stage2 |
1.097790E-01 |
| Normal-vs-Stage3 |
5.597400E-01 |
| Normal-vs-Stage4 |
6.865200E-01 |
| Stage1-vs-Stage2 |
9.717200E-03 |
| Stage1-vs-Stage3 |
1.167050E-01 |
| Stage1-vs-Stage4 |
2.884400E-01 |
| Stage2-vs-Stage3 |
1.511570E-01 |
| Stage2-vs-Stage4 |
1.769610E-01 |
| Stage3-vs-Stage4 |
9.030200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.312400E-01 |
| Normal-vs-AfricanAmerican |
6.962200E-01 |
| Normal-vs-Asian |
8.695400E-01 |
| Caucasian-vs-AfricanAmerican |
5.338200E-01 |
| Caucasian-vs-Asian |
9.973600E-01 |
| AfricanAmerican-vs-Asian |
5.687600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.577000E-01 |
| Normal-vs-Female |
9.341200E-01 |
| Male-vs-Female |
5.538000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.686170E-01 |
| Normal-vs-Age(41-60Yrs) |
5.470600E-01 |
| Normal-vs-Age(61-80Yrs) |
9.193700E-02 |
| Normal-vs-Age(81-100Yrs) |
3.545200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.103300E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.181360E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.106000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.065360E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.344400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.618000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.535200E-01 |
| Classical-VS-Follicular |
4.36370000023167E-07 |
| Classical-VS-Other |
5.879400E-01 |
| Classical-VS-Normal |
2.859600E-01 |
| Tall-VS-Follicular |
2.834100E-02 |
| Tall-VS-Other |
2.691200E-01 |
| Tall-VS-Normal |
9.669400E-01 |
| Follicular-VS-Other |
3.013600E-02 |
| Follicular-VS-Normal |
1.508180E-02 |
| Other-VS-Normal |
3.806200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.793200E-01 |
| Normal-vs-N1 |
1.781950E-01 |
| N0-vs-N1 |
4.864200E-03 |
|
|
